Abstract-We previously reported that thyroid hormone stimulates renin synthesis in vivo and in vitro. Here, we analyzed the 5Ј-flanking sequence of the human renin gene for promoter activity responsive to thyroid hormone using Calu-6 cells, which secrete renin endogenously and express thyroid hormone receptor-␤. The luciferase reporter gene was cloned together with 5Ј-flanking portions of the human renin gene of various lengths into the pGL3-Basic vector. Luciferase activity assays were performed using the Dual Luciferase Reporter Assay System. 3,3Ј,5-Triiodo-L-thyronine stimulated the promoter activity of pGL3-BasicϪ1111/ϩ12 and pGL3-BasicϪ1298/ϩ12 by 2.3Ϯ0.1-and 1.7Ϯ0.1-fold, respectively. Shorter constructs (pGL3-BasicϪ144/ϩ12, pGL3-BasicϪ226/ϩ12, pGL3-BasicϪ452/ϩ12, and pGL3-BasicϪ953/ϩ12) were not stimulated by thyroid hormone. These results suggest that there is a possible thyroid hormone response element (5Ј-AGG TCA GGT CAc aat GTT CCT-3Ј) between nucleotides Ϫ1111 and Ϫ953. In 3 constructs with site-directed mutations in this sequence, basal promoter activities were significantly increased, whereas promoter activation by thyroid hormone was abolished. Electrophoretic mobility shift assays showed that the Ϫ1111/Ϫ953 DNA fragment of the intact human renin gene was bound to nuclear proteins of Calu-6 cells; however, none of the 3 mutant probes were bound to any nuclear proteins. These results suggest that thyroid hormone stimulates the promoter activity of the human renin gene through thyroid hormone response element-dependent mechanisms in Calu-6 cells. 
T he renin-angiotensin system plays a pivotal role in the long-term regulation of blood pressure and electrolyte homeostasis. 1 Although elevated blood pressure should suppress renin release from renal juxtaglomerular cells, high levels of plasma renin are often found in hypertensive patients. 2 Increased plasma renin levels are related to the incidences of stroke, myocardial infarction, and other vascular injuries. 3 Understanding the mechanism that regulates renin gene expression may provide better approaches to the treatment of hypertension.
Renin and renin mRNA are expressed in many cell types, such as in the placental, ovarian, testicular, 4 adrenal, 5 and pituitary 6, 7 cells of a number of species. The expression of renin is particularly high in juxtaglomerular cells. 8 Juxtaglomerular cells are difficult to isolate and culture, and they lose their ability to produce renin after a single passage. 9 Thus, because of the lack of any established renin-producing cell lines, very little is known about the mechanisms that control human renin gene expression.
Recently, Lang et al 10 showed that the cell line Calu-6, derived from human lung cancer, endogenously produces human renin and renin mRNA. Successive studies have demonstrated that renin synthesis in Calu-6 cells, like juxtaglomerular cells, is activated by cAMP 11 and inhibited by mechanical stretch. 12 Therefore, the Calu-6 cell line is a potentially useful model for studying transcriptional regulation of the human renin gene.
We recently reported that thyroid hormone directly stimulates renin mRNA in vivo 13 and in vitro. 14 In the present study, we examined 2 hypotheses: (1) that thyroid hormone increases renin mRNA in Calu-6 cells and (2) that thyroid hormone stimulates the promoter activity of the human renin gene in Calu-6 cells.
attachment to the culture dishes. The culture medium was changed, and Calu-6 cells were treated with or without 10 Ϫ7 mol/L 3,3Ј,5-triiodo-L-thyronine (T 3 ; Aldrich) for 24 hours, because this concentration and incubation time induced the maximum stimulation of renin synthesis in a preliminary study.
Expression of Human Thyroid Hormone Receptor-␤
Calu-6 cells were rinsed 3 times with PBS, collected by scraping, resuspended in 500 L guanidine isothiocyanate, and homogenized with a Polytron homogenizer (Kinematica) for 30 seconds at 4°C. Total RNA from cultured Calu-6 cells was extracted using a total RNA extraction kit (Clontech) according to the manufacturer's protocol.
RT-PCR was performed with the GeneAmp RNA PCR core kit (Perkin-Elmer Cetus). Sense (5Ј-GAG GAG AAG AAA TGT AAA GG-3Ј) and antisense (5Ј-TGT TGC CAT GCC AAC ATA GAT GC-3Ј) primers for PCR amplification of human thyroid hormone receptor-␤ (hTR-␤) cDNA corresponded to hTR-␤ gene nucleotides ϩ250 through ϩ269 and ϩ491 through ϩ513, respectively. 15 PCR was performed for 30 cycles with a 30-second denaturation step at 94°C, a 60-second annealing step at 50°C, and a 75-second extension step at 72°C. The PCR product was sequenced to confirm that it was hTR-␤ cDNA through dideoxy sequencing with the ABI PRISM cycle sequencing kit (Perkin-Elmer Cetus). The sequences obtained were identical to those previously reported. 15 
Expression Analysis
Total RNA from cultured Calu-6 cells was extracted as described earlier. Quantitative RT-PCR was performed precisely as previously described. 16 -18 Sense (5Ј-AAT GAA GGG GGT GTC TGT GG-3Ј) and antisense (5Ј-CAC GAC ATA ATC AAA CAG CC-3Ј) primers for PCR amplification of human renin cDNA corresponded to human renin gene nucleotides ϩ812 through ϩ831 and ϩ952 through ϩ971, respectively. 19 Sense (5Ј-CGG ATT TGG TCG TAT TGG GC-3Ј) and antisense (5Ј-AAA TGA GCC CCA GCC TTC TCC-3Ј) primers for PCR amplification of human glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA corresponded to human GAPDH gene nucleotides ϩ87 through ϩ106 and ϩ375 through ϩ395, respectively. 20 PCR was performed for 30 cycles with a 30-second denaturation step at 94°C, a 60-second annealing step at 57°C, and a 75-second extension step at 72°C. After coamplification of total RNA with each sense and antisense primer, gel electrophoresis exhibited 2 clear bands at 160 and 309 bp that represent the human renin and GAPDH genes, respectively. GAPDH mRNA was used as an internal standard, because thyroid hormone treatment did not alter the quantity of this mRNA in Calu-6 cells. Human renin mRNA expression was determined as the ratio of the human renin to GAPDH band density. The PCR products were sequenced to confirm that they were human renin and human GAPDH cDNA with the ABI PRISM cycle sequencing kit. The sequences obtained were identical to those previously reported. 19, 20 
Constructs
Human genomic DNA was isolated with a GenTLE kit (Takara) from peripheral blood of a healthy volunteer. With this genomic DNA used as a template, overlapping 5Ј-flanking intervals of the human renin gene were isolated by PCR with an LA PCR kit version 2 (Takara). Sense (5Ј-GCC AAG CAT TCA TTA ACC C-3Ј) and antisense (5Ј-GCT GAT CGT AAG GAC TGA ATG AC-3Ј) primers for PCR amplification of human renin 5Ј-flanking area corresponded to human renin gene nucleotides Ϫ2754 through Ϫ2736 (relative to the start site of human gene transcription) and ϩ226 through ϩ248, respectively. 19 Each PCR cycle consisted of a 30-second denaturation step at 94°C, a 60-second annealing step at 54°C, and a 75-second extension step at 72°C, for a total of 30 cycles. The PCR product was cloned into the pT7Blue(R) T-Vector (Novagen) to generate the construct pT7Blue(R)ϩ248/Ϫ2754. Fusions between the 5Ј-flanking overlapping intervals and the luciferase reporter gene were made with the pGL3-Basic vector (Promega). The plasmids pGL3-BasicϪ1298/ϩ12, pGL3-BasicϪ1111/ϩ12, pGL3-BasicϪ953/ϩ12, pGL3-BasicϪ452/ϩ12, pGL3-BasicϪ226/ϩ12, and pGL3-BasicϪ144/ϩ12 have a common 3Ј end at ϩ12 and promoters of varying lengths and were cloned as shown in Figure 1A . Sequences of all constructs were confirmed through dideoxy sequencing with an ABI PRISM cycle sequencing kit.
Transfection Studies
Plasmid DNAs were purified with a commercial kit (Qiagen). Transient DNA transfection was performed with Tfx-20 Reagent (Promega). The culture medium was replaced with serum-free medium shortly before the transfection. Each luciferase reporter plasmid (0.5 g) was cotransfected with 0.5 g of the pRL-TK vector (Promega). When needed, T 3 (10 Ϫ7 mol/L) was added immediately. Twenty-four hours after transfection, the cells were lysed by the addition of 100 L passive lysis buffer (Promega). Luciferase activity assays were performed with the Dual Luciferase Reporter Assay System (Promega) and were read in a TD-20/20 automatic luminometer (Turner Designs). The pRL-TK luciferase activity was used to correct for transfection efficiency, sample loss, and other factors that could affect the results. Experiments in which pRL-TK luciferase activity varied by Ͼ2-fold were discarded. Consequently, when luciferase activities of pRL-TK were evaluated as the transfection efficiency, the efficiency varied within 1.9-fold (maximum 59 840, minimum 32 070, and average 45 694Ϯ1915 luminometric units). In a preliminary study, we examined the relation between transfection time and luciferase activity by using pGL-BasicϪ144/ ϩ12 without T 3 . When cells were harvested 12 hours after transfection, luciferase activity was 25 008Ϯ1124 luminometric units (nϭ6). Luciferase activity significantly increased at 24 and 36 hours (47 308Ϯ3121 and 42 206Ϯ3065 luminometric units, respectively) and then notably decreased at 48 hours to 26 990Ϯ1039 luminometric units. Therefore, as noted above, we harvested cells 24 hours after transfection in the following protocols.
Mutant Study
Domain mutants were generated from pGL3-BasicϪ1111/ϩ12 plasmid with a QuickChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's recommendations. Mutants-1, -2, and -3 (M1, M2, and M3) were changed from 5Ј-AGG TCA-3Ј (Ϫ1066 to Ϫ1061) to 5Ј-TCA AGG-3Ј, from 5Ј-AGG TCA-3Ј (Ϫ1061 to Ϫ1056) to 5Ј-TCA AGG-3Ј, and from 5Ј-GTT CCT-3Ј (Ϫ1051 to Ϫ1046) to 5Ј-TCC TTG-3Ј, respectively (Figure 2A ). The transfection study was performed as described earlier.
Electrophoretic Mobility Shift Assays
Nuclear extracts were prepared from 10 8 confluent Calu-6 cells according to the Hennighausen method. 21 The Ϫ1111/Ϫ953 DNA fragment of the intact human renin gene was 5Ј-end labeled with ␥-32 P-ATP (Amersham Pharmacia Biotech) with T 4 polynucleotide kinase (Takara). Ten micrograms of nuclear protein from Calu-6 cells or bovine serum albumin was incubated for 30 minutes at room temperature in the presence of 0.3 U of poly(dI/dC) in 20 mmol/L Tris-glycine (pH 7.6) and 1 mmol/L EDTA. The 5Ј-labeled probe (0.1 pmol) was added, and the preparation was further incubated for 30 minutes at room temperature. After chilling on ice, the mixture was run on an 8% nondenaturing polyacrylamide gel and exposed for autoradiography. In competition assays, a 200-fold excess of unlabeled Ϫ1111/Ϫ953 DNA fragment of the intact human renin gene or the 3 human renin gene mutants was added to the reaction mixture and incubated for 30 minutes at room temperature before incubation with the labeled probe.
RNase Protection Assays
The levels of hTR-␤, renin, and GAPDH mRNA were also measured by RNase protection of specific oligonucleotide probes using the Multi-NPA Kit (Ambion) according to the manufacturer's protocol. For hTR-␤ mRNA detection, a 53-mer oligonucleotide antisense to the hTR-␤ mRNA with 10 nucleotides mismatched at its 3Ј-end was used. The sequence of this oligomer is 5Ј-CGT GAT ACA GCG GTA GTG ATA CCC GGT GGC TTT GTC ACC ACA Ctc tgt gta gt-3Ј, complementary to nucleotides ϩ312 through ϩ354 of the hTR-␤ gene. 15 To detect renin mRNA, a 51-mer oligonucleotide complementary to the human renin mRNA with 9 nucleotides mismatched at its 3Ј-ends was used. The sequence of this oligomer (5Ј-GGA GCT GGT AGA ACC TGA GAT GTA GGA TGC ACC GGT GTC TAC gtg gca ttg-3Ј) is complementary to nucleotides ϩ873 through ϩ914 of the human renin gene. 19 The lowercase letters of both oligomers represent the mismatched bases. The levels of human GAPDH mRNA were measured in these studies with a commercially available 44-mer (Ambion) that gives a 36-mer nuclease-protected fragment. These probes were 5Ј-end labeled as described earlier. The radiolabeled probe (300 pg Ϸ 4ϫ10 4 cpm) was hybridized to 10 g of sample total RNA and subjected to nuclease treatment. The nuclease-protected oligomers were analyzed by 15% polyacrylamide, 7 mol/L urea gel (Novex) electrophoresis.
Statistical Analysis
Statistical analysis was performed with an unpaired t test or 1-way ANOVA with the post hoc Schéffe F test. All data are presented as meanϮSEM. PϽ0.05 was considered significant.
Results
After RT-PCR with total RNA from Calu-6 cells with hTR-␤-specific primers, gel electrophoresis exhibited 1 clear band at 264 bp that represents the hTR-␤ gene ( Figure 3A ) 
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and confirmed the expression of hTR-␤ in Calu-6 cells. The expression of hTR-␤ was also confirmed with RNase protection assay ( Figure 3B ). The effect of thyroid hormone on the expression of renin mRNA is depicted in Figure 4A . According to quantitative RT-PCR, thyroid hormone significantly increased human renin mRNA levels by 92% (2.30Ϯ0.20 versus 1.20Ϯ0.10, densitometric ratio to GAPDH, Figure 4B ). The enhancement of the expression of the human renin gene by thyroid hormone treatment was also confirmed with RNase protection assay ( Figure 4C ). Densitometric analysis showed that thyroid hormone significantly increased human renin mRNA levels by 98% (2.58Ϯ0.21 versus 1.30Ϯ0.02, densitometric ratio to GAPDH, Figure 4D ).
The effect of varying lengths of the 5Ј-flanking sequence on the promoter activity of the human renin gene is shown in Figure 1B . Under basal conditions, pGL3-BasicϪ144/ϩ12 showed more reporter activity than the parent pGL3-Basic plasmid (1155Ϯ219 luminometric units). Less reporter activity was observed from extracts of cells transfected with pGL3-BasicϪ266/ϩ12 than from those transfected with pGL3-BasicϪ144/ϩ12. pGL3-BasicϪ452/ϩ12 showed more activity than pGL3-BasicϪ226/ϩ12. pGL3-BasicϪ953/ϩ12 demonstrated less activity than pGL3-BasicϪ452/ϩ12. pGL3-BasicϪ1111/ϩ12 and pGL3-BasicϪ1298/ϩ12 exhibited less activity than pGL3-BasicϪ953/ϩ12.
The effect of thyroid hormone on the promoter activity of the human renin gene is shown in Figure 1C . In comparison with basal activity, thyroid hormone stimulated the promoter activity of pGL3-BasicϪ1111/ϩ12 and pGL3-BasicϪ1298/ ϩ12 by 2.3Ϯ0.1-and 1.7Ϯ0.1-fold, respectively. Other shorter constructs did not exhibit stimulation by thyroid hormone.
The effects of mutations in the putative thyroid hormone (THRE) motifs are shown in Figure 2B . Basal promoter activities were significantly increased in M1, M2, and M3 compared with pGL3-BasicϪ1111/ϩ12 (lanes 2 to 4), whereas thyroid hormone did not stimulate promoter activities in mutated constructs (lanes 5 to 7) . When sample RNA and RNase treatments were omitted, 2 bands for full-length probes were shown (lane 1). When sample RNA was excluded, no band was seen, because RNase treatment digested both probes (lane 2). When RNase protection assay was performed with 2 kinds of probe and sample RNA including RNase treatments, 2 shorter fragments that were protected from RNase treatment were confirmed (lane 3). A, Representative blots of renin and GAPDH mRNA levels in Calu-6 cells by RT-PCR. The PCR products were sequenced and were confirmed to be human renin and human GAPDH cDNA. B, Densitometric analysis of the bands shows that thyroid hormone increases renin mRNA expression by 92%. C, Representative blots of renin and GAPDH mRNA levels in Calu-6 cells by RNase protection assay. When RNase protection assay was performed with 2 kinds of probe and sample RNA including RNase treatments, 2 shorter fragments that were protected from RNase treatment were confirmed (lanes 3 to 6). D, Densitometric analysis of the bands shows that thyroid hormone increases renin mRNA expression by 98%. Values shown are meanϮSEM. *PϽ0.01 vs without T 3 . nϭ12.
The interaction of the putative human renin gene THRE with the nuclear proteins of Calu-6 cells was examined with electrophoretic mobility shift assay. Figure 2C shows the binding of Calu-6 cell nuclear extract with the labeled putative THRE. A single specific band appeared with retarded mobility (lane 2). No specific band was observed when the labeled DNA was incubated with bovine serum albumin alone (lane 1). Furthermore, the binding of labeled putative THRE to the nuclear proteins was displaced by the excessive unlabeled DNA fragment of the intact human renin gene (lane 3). The excessive unlabeled DNA fragments of the 3 mutants of the human renin gene did not show any obvious changes in electrophoretic mobility (lanes 4 to 6).
Discussion
Expression of renin mRNA in Calu-6 cells was increased by thyroid hormone in the same manner as in primary cultured juxtaglomerular cells, suggesting that Calu-6 cells may provide a good model to study the effect of thyroid hormone on transcriptional changes in the renin gene. The 5Ј-flanking DNA sequence Ϫ144/ϩ12 appears to contain the human renin gene promoter. The same region (Ϫ149/ϩ13, 10 Ϫ148/ ϩ11, 22 and Ϫ148/ϩ18, 23 and Ϫ137/ϩ16 24 ) was also identified as the human renin gene promoter using Calu-6, GC rat lactotrope precursor, and JEG-3 human choriocarcinoma cell lines. These consistent findings among different cell lines support the notion that this 150-to 160-nucleotide stretch in the 5Ј area of the human renin gene does contain the promoter.
Our results also suggested that the 5Ј-flanking DNA sequences, Ϫ226/Ϫ144, Ϫ953/Ϫ452, and Ϫ1111/Ϫ953, contain a negative regulatory element ( Figure 1B) , which is consistent with the findings of Lang et al , 10 Sun et al, 22, 23 and Borensztein et al. 24 The 5Ј-flanking DNA sequence Ϫ452/ Ϫ226 appears to contain a positive regulatory element (Figure 1B) , which is also consistent with the findings of Sun et al. 22 However, pGL3-BasicϪ1111/ϩ12 and pGL3-BasicϪ1298/ϩ12 repressed promoter activity ( Figure 1B) .
The sequences Ϫ1111/ϩ12 and Ϫ1298/ϩ12 had significantly increased promoter activity with thyroid hormone treatment; constructs with sequences Ϫ144/ϩ12, Ϫ226/ϩ12, Ϫ452/ϩ12, and Ϫ953/ϩ12 did not show any significant changes. These stimulatory effects of T 3 on luciferase activity with constructs pGL3-BasicϪ1111/ϩ12 and Ϫ1298/ϩ12 suggest that hTR-␤ bound to THRE and activated basal promoter activity in the presence of thyroid hormone. Because the shorter construct did not show any response to T 3 , the sequence between Ϫ1111 and Ϫ953 may contain a THRE.
We found 3 candidate THRE motifs (5Ј-AGG TCA-3Ј) in sequence Ϫ1111/Ϫ953: (1) 5Ј-AGG TCA-3Ј (Ϫ1066 to Ϫ1061), (2) 5Ј-AGG TCA-3Ј (Ϫ1061 to Ϫ1056), and (3) 5Ј-GTT CCT-3Ј (Ϫ1051 to Ϫ1046). The most common motifs of THRE are an inverted palindrome without spaces (AGG TCA TGA CCT) 25 and a direct repeat with 4 spaces (AGG TCA (n) 4 AGG TCA). 26 However, other patterns have been recently reported to be THREs. 27, 28 When variation in the THRE motif is taken into account, it is possible that the perfect direct repeat without space (5Ј-AGG TCA GGT CA-3Ј, Ϫ1066 to Ϫ1056) and the nearly perfect inverted palindrome spaced by 4 bp (5Ј-AGG TCA caa tGT TCC T-3Ј, Ϫ1061 to Ϫ1046) are putative THREs.
Nucleotides 5Ј-AGG TCA GGT CAc aat GTT CCT-3Ј (Ϫ1066 to Ϫ1046) inhibited renin gene promoter activity. It has been reported that hTR-␤ constitutively binds to THRE and represses basal promoter activity in the absence of thyroid hormone. It is possible that hTR-␤ could not bind the mutated THRE motif sequences in the present study and therefore could not repress basal promoter activity. In addition, the stimulatory effect of thyroid hormone was abolished by each mutation, indicating that thyroid hormone and hTR-␤ cannot form a complex on the mutated THRE.
The electrophoretic mobility shift assay data ( Figure 2C ) further confirmed that the intact putative THRE is important for binding with Calu-6 cell nuclear extract and that all 3 putative motifs are essential for the interaction of the putative THRE of the human renin gene with Calu-6 cell nuclear proteins. This result is consistent with the luciferase assay studies shown in Figure 2B . In Figure 2B , each mutated construct lost all thyroid hormone responsiveness, whereas each construct had intact 2 putative motifs. It is, however, still not clear why the remaining 2 motifs in each mutant DNA fragment of the human renin gene, M1, M2, and M3, did not compete with intact DNA probe. It is possible that the binding ability of DNA with 3 intact motifs is so potent that the remaining 2 motifs in mutated DNA cannot replace the binding between wild-type DNA and the nuclear proteins. Previous reports showed that 3 motifs worked as 1 THRE in the ␣-myosin heavy chain, 29 growth hormone, 30 and malic enzyme 31 genes. Sugawara et al 32 examined the role of 3 THRE motifs in the growth hormone gene and, consistent with our present data, found that the interaction of THRE and hTR-␤ was lost when 1 of 3 putative motifs was mutated, suggesting that all 3 half-sites are necessary.
In conclusion, we present the following findings. (1) Thyroid hormone stimulated renin mRNA expression in Calu-6 cells. (2) Thyroid hormone stimulated the promoter activity of the pGL3-BasicϪ1111/ϩ12 and the pGL3-BasicϪ1298/ϩ12 by 2.3Ϯ0.1-and 1.7Ϯ0.1-fold over basal levels, respectively; however, other shorter constructs (pGL3-BasicϪ144/ϩ12, pGL3-BasicϪ226/ϩ12, pGL3-BasicϪ452/ ϩ12, and pGL3-BasicϪ953/ϩ12) were not stimulated by thyroid hormone. (3) In sequence Ϫ1111/Ϫ953, there is a 5Ј-AGG TCA GGT CAc aat GTT CCT-3Ј sequence that may be a THRE. Mutant studies indicated that hTR-␤ could not repress the basal promoter activity in the absence of thyroid hormone. (4) The intact motif of the putative THRE is important for binding to Calu-6 cell nuclear proteins. These results suggest that thyroid hormone stimulates the promoter activity of the human renin gene through a THRE-dependent mechanism in Calu-6 cells. 
